Annual CFI
$8.95 M
+$19.68 M+183.36%
31 December 2023
Summary:
ClearPoint Neuro annual cash flow from investing activities is currently $8.95 million, with the most recent change of +$19.68 million (+183.36%) on 31 December 2023. During the last 3 years, it has risen by +$9.43 million (+1956.64%). CLPT annual CFI is now at all-time high.CLPT Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$12.00 K
-$12.00 K-100.00%
30 September 2024
Summary:
ClearPoint Neuro quarterly cash flow from investing activities is currently -$12.00 thousand, with the most recent change of -$12.00 thousand (-100.00%) on 30 September 2024. Over the past year, it has increased by +$223.00 thousand (+94.89%). CLPT quarterly CFI is now -100.10% below its all-time high of $11.75 million, reached on 31 December 2022.CLPT Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$200.00 K
+$223.00 K+52.72%
30 September 2024
Summary:
ClearPoint Neuro TTM cash flow from investing activities is currently -$200.00 thousand, with the most recent change of +$223.00 thousand (+52.72%) on 30 September 2024. Over the past year, it has dropped by -$21.08 million (-100.96%). CLPT TTM CFI is now -100.96% below its all-time high of $20.88 million, reached on 30 September 2023.CLPT TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLPT Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +183.4% | +94.9% | -101.0% |
| 3 y3 years | +1956.6% | +90.4% | -17.0% |
| 5 y5 years | +10000.0% | -17.6% | -24.2% |
CLPT Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +183.4% | -100.1% | +99.9% | -101.0% | +99.1% |
| 5 y | 5 years | at high | +183.4% | -100.1% | +99.9% | -101.0% | +99.1% |
| alltime | all time | at high | +183.4% | -100.1% | +99.9% | -101.0% | +99.1% |
ClearPoint Neuro Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$12.00 K(<-9900.0%) | -$200.00 K(-52.7%) |
| June 2024 | - | $0.00(0.0%) | -$423.00 K(-104.7%) |
| Mar 2024 | - | $0.00(-100.0%) | $9.09 M(+1.5%) |
| Dec 2023 | $8.95 M(-183.4%) | -$188.00 K(-20.0%) | $8.95 M(-57.1%) |
| Sept 2023 | - | -$235.00 K(-102.5%) | $20.88 M(+1.9%) |
| June 2023 | - | $9.51 M(-6991.3%) | $20.49 M(-291.7%) |
| Mar 2023 | - | -$138.00 K(-101.2%) | -$10.69 M(-0.4%) |
| Dec 2022 | -$10.74 M(+6290.5%) | $11.75 M(-1961.5%) | -$10.74 M(-52.3%) |
| Sept 2022 | - | -$631.00 K(-97.1%) | -$22.52 M(+2.3%) |
| June 2022 | - | -$21.67 M(>+9900.0%) | -$22.01 M(+6933.2%) |
| Mar 2022 | - | -$185.00 K(+386.8%) | -$313.00 K(+86.3%) |
| Dec 2021 | -$168.00 K(-65.1%) | -$38.00 K(-69.6%) | -$168.00 K(-1.8%) |
| Sept 2021 | - | -$125.00 K(-457.1%) | -$171.00 K(+271.7%) |
| June 2021 | - | $35.00 K(-187.5%) | -$46.00 K(-43.2%) |
| Mar 2021 | - | -$40.00 K(-2.4%) | -$81.00 K(-83.2%) |
| Dec 2020 | -$482.00 K(+201.3%) | -$41.00 K(<-9900.0%) | -$482.00 K(+9.3%) |
| Sept 2020 | - | $0.00(0.0%) | -$440.80 K(-2.3%) |
| June 2020 | - | $0.00(-100.0%) | -$451.00 K(-25.0%) |
| Mar 2020 | - | -$441.00 K(<-9900.0%) | -$601.00 K(+275.6%) |
| Dec 2019 | -$160.00 K(+152.0%) | $200.00(-102.0%) | -$160.00 K(-0.6%) |
| Sept 2019 | - | -$10.20 K(-93.2%) | -$161.00 K(-0.6%) |
| June 2019 | - | -$150.00 K(<-9900.0%) | -$162.00 K(+277.6%) |
| Mar 2019 | - | $0.00(-100.0%) | -$42.90 K(-32.4%) |
| Dec 2018 | -$63.50 K | -$800.00(-92.9%) | -$63.50 K(-2.2%) |
| Sept 2018 | - | -$11.20 K(-63.8%) | -$64.90 K(-13.6%) |
| June 2018 | - | -$30.90 K(+50.0%) | -$75.10 K(+58.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | -$20.60 K(+836.4%) | -$47.30 K(+77.2%) |
| Dec 2017 | -$26.80 K(-73.5%) | -$2200.00(-89.7%) | -$26.70 K(+6.0%) |
| Sept 2017 | - | -$21.40 K(+590.3%) | -$25.20 K(+563.2%) |
| June 2017 | - | -$3100.00(<-9900.0%) | -$3800.00(-83.8%) |
| Mar 2017 | - | $0.00(-100.0%) | -$23.40 K(-76.8%) |
| Dec 2016 | -$101.00 K(+31.3%) | -$700.00(<-9900.0%) | -$101.00 K(-4.0%) |
| Sept 2016 | - | $0.00(-100.0%) | -$105.20 K(-38.0%) |
| June 2016 | - | -$22.70 K(-70.7%) | -$169.80 K(+14.9%) |
| Mar 2016 | - | -$77.60 K(+1483.7%) | -$147.80 K(+92.4%) |
| Dec 2015 | -$76.90 K(+59.9%) | -$4900.00(-92.4%) | -$76.80 K(-29.2%) |
| Sept 2015 | - | -$64.60 K(+9128.6%) | -$108.40 K(+116.8%) |
| June 2015 | - | -$700.00(-89.4%) | -$50.00 K(-4.4%) |
| Mar 2015 | - | -$6600.00(-81.9%) | -$52.30 K(+8.7%) |
| Dec 2014 | -$48.10 K(-72.4%) | -$36.50 K(+488.7%) | -$48.10 K(+287.9%) |
| Sept 2014 | - | -$6200.00(+106.7%) | -$12.40 K(-90.0%) |
| June 2014 | - | -$3000.00(+25.0%) | -$124.00 K(-26.6%) |
| Mar 2014 | - | -$2400.00(+200.0%) | -$168.90 K(-3.2%) |
| Dec 2013 | -$174.50 K(+36.9%) | -$800.00(-99.3%) | -$174.50 K(-16.1%) |
| Sept 2013 | - | -$117.80 K(+145.9%) | -$207.90 K(+111.1%) |
| June 2013 | - | -$47.90 K(+498.8%) | -$98.50 K(-24.8%) |
| Mar 2013 | - | -$8000.00(-76.6%) | -$130.90 K(+2.7%) |
| Dec 2012 | -$127.50 K(+388.5%) | -$34.20 K(+307.1%) | -$127.40 K(+36.7%) |
| Sept 2012 | - | -$8400.00(-89.5%) | -$93.20 K(+9.9%) |
| June 2012 | - | -$80.30 K(+1684.4%) | -$84.80 K(+1784.4%) |
| Mar 2012 | - | -$4500.00 | -$4500.00 |
| Dec 2011 | -$26.10 K(-57.7%) | - | - |
| Dec 2010 | -$61.70 K | - | - |
FAQ
- What is ClearPoint Neuro annual cash flow from investing activities?
- What is the all time high annual CFI for ClearPoint Neuro?
- What is ClearPoint Neuro annual CFI year-on-year change?
- What is ClearPoint Neuro quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for ClearPoint Neuro?
- What is ClearPoint Neuro quarterly CFI year-on-year change?
- What is ClearPoint Neuro TTM cash flow from investing activities?
- What is the all time high TTM CFI for ClearPoint Neuro?
- What is ClearPoint Neuro TTM CFI year-on-year change?
What is ClearPoint Neuro annual cash flow from investing activities?
The current annual CFI of CLPT is $8.95 M
What is the all time high annual CFI for ClearPoint Neuro?
ClearPoint Neuro all-time high annual cash flow from investing activities is $8.95 M
What is ClearPoint Neuro annual CFI year-on-year change?
Over the past year, CLPT annual cash flow from investing activities has changed by +$19.68 M (+183.36%)
What is ClearPoint Neuro quarterly cash flow from investing activities?
The current quarterly CFI of CLPT is -$12.00 K
What is the all time high quarterly CFI for ClearPoint Neuro?
ClearPoint Neuro all-time high quarterly cash flow from investing activities is $11.75 M
What is ClearPoint Neuro quarterly CFI year-on-year change?
Over the past year, CLPT quarterly cash flow from investing activities has changed by +$223.00 K (+94.89%)
What is ClearPoint Neuro TTM cash flow from investing activities?
The current TTM CFI of CLPT is -$200.00 K
What is the all time high TTM CFI for ClearPoint Neuro?
ClearPoint Neuro all-time high TTM cash flow from investing activities is $20.88 M
What is ClearPoint Neuro TTM CFI year-on-year change?
Over the past year, CLPT TTM cash flow from investing activities has changed by -$21.08 M (-100.96%)